US Ecology upgraded by Kansas City Capital with a new price target
$ECOL
Environmental Services
Public Utilities
Kansas City Capital upgraded US Ecology from Perform to Outperform and set a new price target of $49.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/19/2021 | $42.00 → $32.00 | Buy → Hold | Stifel |
| 10/19/2021 | $42.00 → $31.00 | Buy → Hold | Stifel |
SC 13G/A - US Ecology, Inc. (0001783400) (Subject)
SC 13D - US Ecology, Inc. (0001783400) (Subject)
SC 13G - US Ecology, Inc. (0001783400) (Subject)
BOISE, Idaho, Feb. 25, 2022 (GLOBE NEWSWIRE) -- US Ecology, Inc. (NASDAQ-GS: ECOL) ("US Ecology" or "the Company") today reported results for the fourth quarter and year ended December 31, 2021. FOURTH QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: Total revenue increases 8% to $261.4 millionWaste Solutions Base Business grows 9% on improving underlying fundamentalsWaste Solutions Event Business rebounds with 15% growth Field Services segment revenue declines 4% due to difficult comparison to prior year Energy Waste recovery continues; revenue more than doubles and adjusted EBITDA margin improves to 35% Net Income of $3.6 million, earnings per diluted share of $0.
THIRD QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR: Waste Solutions Base Business growth accelerates to 11% on strong underlying fundamentalsWaste Solutions Event Business declines 18% due to ongoing project deferments and service mixField Services segment revenue grows 5% despite difficult comparison to last year Energy Waste recovery continues; revenue doubling and adjusted EBITDA margin improving to 34% Total revenue increases 8% to $257.2 millionNet Income of $6.7 million, earnings per diluted share of $0.21 Adjusted EBITDA of $45.4 millionAdjusted free cash flow of $14.9 million BOISE, Idaho, Nov. 05, 2021 (GLOBE NEWSWIRE) -- US Ecology, Inc. (NASDAQ-GS: ECOL) ("US Ecology" or "the Com
BOISE, Idaho, Oct. 18, 2021 (GLOBE NEWSWIRE) -- US Ecology, Inc. (the "Company") (NASDAQ:ECOL) today announced that it will release financial results for the third quarter ended September 30, 2021 before market open on Friday, November 5, 2021. Management will also conduct an investor conference call on Friday, November 5, 2021 at 11:00 a.m. Eastern Time (9:00 a.m. Mountain Time) to discuss these results. Questions will be invited after management's presentation. Interested parties can access the conference call by dialing 877-512-4138 or 412-317-5478. The conference call will also be broadcast live on the Company's website at http://investors.usecology.com/events-and-presentations.as
Stifel downgraded US Ecology from Buy to Hold and set a new price target of $32.00 from $42.00 previously
Stifel downgraded US Ecology from Buy to Hold and set a new price target of $31.00 from $42.00 previously
Kansas City Capital upgraded US Ecology from Perform to Outperform and set a new price target of $49.00
Estimated $75 million to $100 million of cross-selling revenue opportunity between Republic's existing $1.5 billion manufacturing portfolio and US Ecology's $1 billion portfolioProvides customers a single partner to manage their multiple waste streams efficiently and sustainably through a national footprint of vertically integrated assetsTransaction expected to be immediately accretive to adjusted earnings and free cash flow, with $40 million of cost synergies expected to be achieved within the first three yearsPHOENIX, May 2, 2022 /PRNewswire/ -- Republic Services, Inc. (NYSE:RSG) announced today that it completed its acquisition of all outstanding shares of US Ecology, Inc. (NASDAQ-GS: ECO
NEW YORK, April 28, 2022 /PRNewswire/ -- Inari Medical Inc. (NASD:NARI) will replace Tri Pointe Homes Inc. (NYSE:TPH) in the S&P MidCap 400, and Tri Pointe Homes will replace US Ecology Inc. (NASD:ECOL) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, May 3. S&P 500 constituent Republic Services Inc. (NYSE:RSG) is acquiring US Ecology in a transaction expected to close on or about May 2. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector May 3, 2022 S&P MidCap 400 Addition Inari Medical NARI Health Care S&P MidCap 400 Deletion Tri Po
PHOENIX and BOISE, Idaho, March 31, 2022 /PRNewswire/ -- Republic Services, Inc. (NYSE:RSG) and US Ecology, Inc. (NASDAQ-GS: ECOL) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, which applies to the proposed acquisition by Republic Services of US Ecology, expired at 11:59 p.m. Eastern Time, on March 30, 2022. The transaction is expected to close during the second quarter, subject to approval by US Ecology's stockholders and satisfaction of the remaining conditions to closing. About Republic Services Republic Services, Inc. is a leader in the U.S. environmental services industry. Through its subsidiaries, the Company provide
15-12B - US Ecology, Inc. (0001783400) (Filer)
S-8 POS - US Ecology, Inc. (0001783400) (Filer)
S-8 POS - US Ecology, Inc. (0001783400) (Filer)
4 - US Ecology, Inc. (0001783400) (Issuer)
4 - US Ecology, Inc. (0001783400) (Issuer)
4 - US Ecology, Inc. (0001783400) (Issuer)
CAMBRIDGE, England & BOSTON & SEATTLE--(BUSINESS WIRE)--NodThera, a biotechnology company developing a new class of medicines that inhibit the NLRP3 inflammasome to treat chronic inflammation, today announced the expansion of its senior leadership team with the appointments of Donald Johns, M.D., as Chief Medical Officer and Katina Dorton, J.D., MBA, as Chief Financial Officer. Dr. Johns is an accomplished drug development leader and board-certified clinical neurologist who previously served as Chief Medical Officer and Executive Vice President of Medical and Scientific Affairs at Syntimmune, prior to the company’s acquisition by Alexion Pharmaceuticals. Ms. Dorton is a recognized
WATERTOWN, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, today announced the appointment of Katina Dorton, J.D., M.B.A., to Pandion’s board of directors and as chair of the audit committee. Ms. Dorton assumes the position of chair of the audit committee from Christopher Fuglesang, Ph.D., J.D., who will continue to serve as a member of the board and audit committee. Mitchell Mutz, Ph.D., resigned from the Company’s board on December 2, 2020. “Ms. Dorton brings to Pandion over two decades of financial expe